feed,title,long_url,short_url
Benzinga,Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years,https://benzinga.com/general/biotech/22/07/28061327/regeneron-sanofis-dupixent-hits-primary-goal-in-esophagitis-patients-below-11-years,https://bit.ly/3O0tTME
